FSN-013 or Placebo administered orally

2 trials

Sponsors

Takayanagi Toshiaki

Conditions

dysmenorrheaendometriosis

Phase 3

A study of FSN-013 in Japanese patients with dysmenorrhea

Active, not recruitingJPRN-jRCT2011210023

Takayanagi Toshiakidysmenorrhea

Start: 2021-08-02Target: 150Updated: 2026-06-29

A study of FSN-013 in Japanese patients with endometriosis

RecruitingJPRN-jRCT2031250241

Takayanagi Toshiakiendometriosis

Start: 2025-08-21Target: 173Updated: 2026-06-29

Related Papers

Post Hoc Analysis of a Previous Study of Estetrol 15 mg/Drospirenone 3 mg Combination for Dysmenorrhea and Uterine Bleeding in Adenomyosis Patients

Reproductive Medicine and Biology2026-01-01

Efficacy and safety of estetrol (15 mg)/drospirenone (3 mg) combination in a cyclic regimen for the treatment of primary and secondary dysmenorrhea: a multicenter, placebo-controlled, double-blind, randomized study.

2024-11-083 citations